by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials
Conditions: Glioblastoma; High-Grade Glioma (WHO III-IV); High-grade Glioma; Diffuse Midline Glioma, H3 K27M-Mutant; Diffuse Hemispheric Glioma, H3G34 Mutant Interventions: Drug: ADI-PEG 20 (Arginine deiminase pegylated); Drug: Temozolomide (TMZ); Radiation:...
by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials
Conditions: Extensive-stage Small Cell Lung Cancer (SCLC) Interventions: Drug: Yishen Qutong Granules; Drug: Yishen Qutong Simulant Granules Sponsors: LI FENG; Henan Cancer Hospital; Fudan University; Shanxi Province Cancer Hospital Enrolling by...
by palligoelme@gmail.com | Feb 5, 2026 | Clinical Trials
Conditions: Breast Cancer; Breast Cancer With Low to Intermediate HER2 Expression Interventions: Other: DCE-MRI Sponsors: Hao Xu Not yet recruiting Conditions: Breast Cancer; Breast Cancer With Low to Intermediate HER2 Expression Interventions: Other: DCE-MRI...
by palligoelme@gmail.com | Feb 4, 2026 | Clinical Trials
Conditions: Knee Osteoarthristis Interventions: Procedure: Genicular Artery Embolization Sponsors: Joint & Vascular Institute Recruiting Conditions: Knee Osteoarthristis Interventions: Procedure: Genicular Artery Embolization Sponsors: Joint & Vascular...
by palligoelme@gmail.com | Feb 4, 2026 | Clinical Trials
Conditions: Short Chain Fatty Acids Concentration in Stools; Gut Microbiota Diversity and Composition Interventions: Dietary Supplement: Moderate Vitamin C dose (200 mg); Dietary Supplement: High-dose vitamin C supplementation (1000 mg); Other: Habitual diet (run in...